Sympathetic neural overactivity in healthy humans after prolonged exposure to hypobaric hypoxia.
Acute exposure to hypoxia causes chemoreflex activation of the sympathetic nervous system. During acclimatization to high altitude hypoxia, arterial oxygen content recovers, but it is unknown to what degree sympathetic activation is maintained or normalized during prolonged exposure to hypoxia. We therefore measured sympathetic nerve activity directly by peroneal microneurography in eight healthy volunteers (24 +/- 2 years of age) after 4 weeks at an altitude of 5260 m (Chacaltaya, Bolivian Andes) and at sea level (Copenhagen). The subjects acclimatized well to altitude, but in every subject sympathetic nerve activity was highly elevated at altitude vs. sea level (48 +/- 5 vs. 16 +/- 3 bursts min(-1), respectively, P < 0.05), coinciding with increased mean arterial blood pressure (87 +/- 3 vs. 77 +/- 2 mmHg, respectively, P < 0.05). To examine the underlying mechanisms, we administered oxygen (to eliminate chemoreflex activation) and saline (to reduce cardiopulmonary baroreflex deactivation). These interventions had minor effects on sympathetic activity (48 +/- 5 vs. 38 +/- 4 bursts min(-1), control vs. oxygen + saline, respectively, P < 0.05). Moreover, sympathetic activity was still markedly elevated (37 +/- 5 bursts min(-1)) when subjects were re-studied under normobaric, normoxic and hypervolaemic conditions 3 days after return to sea level. In conclusion, acclimatization to high altitude hypoxia is accompanied by a striking and long-lasting sympathetic overactivity. Surprisingly, chemoreflex activation by hypoxia and baroreflex deactivation by dehydration together could account for only a small part of this response, leaving the major underlying mechanisms unexplained.
Hansen
Jim
J
Copenhagen Muscle Research Centre, Rigshospitalet, Copenhagen, Denmark. jimhansen@dadlnet.dk
Sander
Mikael
M
D000064:Acclimatization; D000328:Adult; D000532:Altitude Sickness / Q000503:physiopathology; D001274:Atmospheric Pressure; D001810:Blood Volume / Q000187:drug effects; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000209:etiology* / Q000503:physiopathology*; D008297:Male; D018482:Muscle, Skeletal / Q000294:innervation; D010100:Oxygen; D012119:Respiration; D012965:Sodium Chloride / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000503:physiopathology*
D012965:Sodium Chloride; D010100:Oxygen